Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoadjuvant Operable Breast Cancer × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 10998 Triple Negative Breast Neoplasms 932 Neoplasms 633 Ovarian Neoplasms 553 Neoplasm Metastasis 504 Lung Neoplasms 488 Colorectal Neoplasms 478 Prostatic Neoplasms 472 Carcinoma, Non-Small-Cell Lung 453 Pancreatic Neoplasms 324 Melanoma 303 Stomach Neoplasms 287 Colonic Neoplasms 274 Breast Neoplasms, Male 247 Motor Activity 241 Carcinoma, Intraductal, Noninfiltrating 228 Head and Neck Neoplasms 221 Endometrial Neoplasms 216 Uterine Cervical Neoplasms 215 Carcinoma, Renal Cell 178 Sarcoma 174 Urinary Bladder Neoplasms 165 Squamous Cell Carcinoma of Head and Neck 159 Esophageal Neoplasms 159 Brain Neoplasms 158 Lymphedema 157 Breast Carcinoma In Situ 154 Fatigue 141 Carcinoma, Ovarian Epithelial 131 Breast Cancer Female 131

Interventions

palbociclib 1 Letrozole 1 Fluorouracil 1 Epirubicin 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02400567 2022-03-15

NeoPAL

UNICANCER

Phase 2 Completed

Neoadjuvant Operable Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡